Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateTimeSourceHeadlineSymbolCompany
05/05/20208:02PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Portola Pharmaceuticals, Inc.NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/20205:07PMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/20205:06PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/20204:02PMPR Newswire (US)Portola Pharmaceuticals Cancels First Quarter 2020 Financial Results Webcast and Conference Call Following Agreement to be Ac...NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/20203:10PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Portola Pharmaceuticals, Inc.NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/20202:23PMPR Newswire (US)Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law FirmNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202012:39PMPR Newswire (US)Portola Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Portola Pharmaceuticals, Inc....NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202010:48AMPR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Portola Pharmaceuticals, Inc. has obtained a Fair Price in its...NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/20207:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/20207:20AMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/01/20204:23PMPR Newswire (US)Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
04/23/20204:21PMPR Newswire (US)Portola Pharmaceuticals to Announce First Quarter 2020 Financial Results on Monday, May 11, 2020NASDAQ:PTLAPortola Pharmaceuticals Inc
04/20/20205:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
04/20/20205:05PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
04/09/20206:29AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
04/09/20206:08AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
04/07/20208:00AMPR Newswire (US)Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid ...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/01/20204:02PMPR Newswire (US)Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/18/20204:11PMPR Newswire (US)Portola Pharmaceuticals Announces Proactive Steps Supporting Public Health Efforts to Combat Coronavirus (COVID-19)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/16/20208:05AMPR Newswire (US)Portola Pharmaceuticals Announces Results Demonstrating Andexxa® was Associated with Lowest Rate of Mortality in Patients wi...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/05/20208:30AMPR Newswire (US)New Data Demonstrates Andexxa® Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/03/20206:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/03/20206:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/03/20203:59PMBusiness WireShareholder Alert: Robbins LLP Announces Another Complaint Filed Against Portola Pharmaceuticals, Inc. (PTLA)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/02/20204:57PMPR Newswire (US)Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/02/202011:27AMBusiness WireFederman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Portola ...NASDAQ:PTLAPortola Pharmaceuticals Inc
02/28/20204:12PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/27/20207:52PMBusiness WirePTLA INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors in Portola Pharmaceuticals, Inc. of a Filing Deadline in ...NASDAQ:PTLAPortola Pharmaceuticals Inc
02/26/20204:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/26/20204:01PMPR Newswire (US)Portola Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Your Recent History

Delayed Upgrade Clock